Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Fcho2 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | FCHO2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FCHO2 mRNA | CTD | PMID:22079256 | Fcho2 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Fcho2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of FCHO2 mRNA | CTD | PMID:22206623 | Fcho2 | Rat | 17beta-estradiol | decreases expression | ISO | Fcho2 (Mus musculus) | 6480464 | Estradiol results in decreased expression of FCHO2 mRNA | CTD | PMID:19484750 | Fcho2 | Rat | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of FCHO2 mRNA | CTD | PMID:32145629 | Fcho2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Fcho2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FCHO2 mRNA | CTD | PMID:21570461 | Fcho2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of FCHO2 mRNA | CTD | PMID:34747641 | Fcho2 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | Fcho2 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of FCHO2 mRNA | CTD | PMID:30851411 | Fcho2 | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Fcho2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of FCHO2 mRNA | CTD | PMID:26251327 | Fcho2 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | FCHO2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FCHO2 mRNA | CTD | PMID:28628672 | Fcho2 | Rat | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of FCHO2 mRNA | CTD | PMID:30779732 | Fcho2 | Rat | antirheumatic drug | decreases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of FCHO2 mRNA | CTD | PMID:24449571 | Fcho2 | Rat | aristolochic acid A | decreases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of FCHO2 mRNA | CTD | PMID:33212167 | Fcho2 | Rat | arsane | affects methylation | ISO | FCHO2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of FCHO2 gene | CTD | PMID:25304211 | Fcho2 | Rat | arsenic atom | affects methylation | ISO | FCHO2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of FCHO2 gene | CTD | PMID:25304211 | Fcho2 | Rat | arsenite(3-) | multiple interactions | ISO | FCHO2 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to FCHO2 mRNA] | CTD | PMID:32406909 | Fcho2 | Rat | benzo[a]pyrene | decreases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of FCHO2 mRNA | CTD | PMID:20064835 | Fcho2 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | Fcho2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FCHO2 mRNA | CTD | PMID:25181051 and PMID:33296240 | Fcho2 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of FCHO2 mRNA | CTD | PMID:32145629 | Fcho2 | Rat | bisphenol F | multiple interactions | ISO | FCHO2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FCHO2 mRNA | CTD | PMID:28628672 | Fcho2 | Rat | caffeine | affects phosphorylation | ISO | FCHO2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of FCHO2 protein | CTD | PMID:35688186 | Fcho2 | Rat | cisplatin | increases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of FCHO2 mRNA | CTD | PMID:27392435 | Fcho2 | Rat | coumarin | affects phosphorylation | ISO | FCHO2 (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of FCHO2 protein | CTD | PMID:35688186 | Fcho2 | Rat | crocidolite asbestos | decreases expression | ISO | Fcho2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of FCHO2 mRNA | CTD | PMID:29279043 | Fcho2 | Rat | dexamethasone | multiple interactions | ISO | FCHO2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FCHO2 mRNA | CTD | PMID:28628672 | Fcho2 | Rat | Dibutyl phosphate | affects expression | ISO | FCHO2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of FCHO2 mRNA | CTD | PMID:37042841 | Fcho2 | Rat | doxorubicin | decreases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of FCHO2 mRNA | CTD | PMID:29803840 | Fcho2 | Rat | FR900359 | affects phosphorylation | ISO | FCHO2 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of FCHO2 protein | CTD | PMID:37730182 | Fcho2 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of FCHO2 mRNA | CTD | PMID:26194646 | Fcho2 | Rat | genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of FCHO2 protein | CTD | PMID:24552547 | Fcho2 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of FCHO2 mRNA | CTD | PMID:22061828 | Fcho2 | Rat | indometacin | multiple interactions | ISO | FCHO2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FCHO2 mRNA | CTD | PMID:28628672 | Fcho2 | Rat | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of FCHO2 mRNA | CTD | PMID:30467583 | Fcho2 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of FCHO2 mRNA | CTD | PMID:25729387 | Fcho2 | Rat | ozone | multiple interactions | ISO | Fcho2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FCHO2 mRNA | CTD | PMID:27106289 | Fcho2 | Rat | paracetamol | affects expression | ISO | Fcho2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of FCHO2 mRNA | CTD | PMID:17562736 | Fcho2 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of FCHO2 mRNA | CTD | PMID:33387578 | Fcho2 | Rat | paracetamol | decreases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of FCHO2 mRNA | CTD | PMID:21420995 | Fcho2 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of FCHO2 mRNA | CTD | PMID:27153767 | Fcho2 | Rat | phenobarbital | increases expression | ISO | Fcho2 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of FCHO2 mRNA | CTD | PMID:19270015 | Fcho2 | Rat | phenobarbital | affects expression | ISO | Fcho2 (Mus musculus) | 6480464 | Phenobarbital affects the expression of FCHO2 mRNA | CTD | PMID:23091169 | Fcho2 | Rat | potassium chromate | decreases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of FCHO2 mRNA | CTD | PMID:22079256 | Fcho2 | Rat | potassium chromate | multiple interactions | ISO | FCHO2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FCHO2 mRNA | CTD | PMID:22079256 | Fcho2 | Rat | rac-lactic acid | decreases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of FCHO2 mRNA | CTD | PMID:30851411 | Fcho2 | Rat | sodium arsenate | increases expression | ISO | Fcho2 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of FCHO2 mRNA | CTD | PMID:21795629 | Fcho2 | Rat | sodium arsenite | decreases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of FCHO2 protein | CTD | PMID:30528433 | Fcho2 | Rat | sulforaphane | decreases expression | ISO | Fcho2 (Mus musculus) | 6480464 | sulforaphane results in decreased expression of FCHO2 mRNA | CTD | PMID:30529165 | Fcho2 | Rat | testosterone | increases expression | ISO | Fcho2 (Mus musculus) | 6480464 | Testosterone deficiency results in increased expression of FCHO2 mRNA | CTD | PMID:33848595 | Fcho2 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of FCHO2 mRNA | CTD | PMID:25729387 | Fcho2 | Rat | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of FCHO2 mRNA | CTD | PMID:25729387 | Fcho2 | Rat | triphenyl phosphate | affects expression | ISO | FCHO2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of FCHO2 mRNA | CTD | PMID:37042841 | Fcho2 | Rat | urethane | decreases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | Urethane results in decreased expression of FCHO2 mRNA | CTD | PMID:28818685 | Fcho2 | Rat | valproic acid | decreases expression | ISO | FCHO2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of FCHO2 mRNA | CTD | PMID:23179753 and PMID:29154799 | |